Alyeska Investment Group’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-937,500
Closed -$1.64M 653
2025
Q1
$1.64M Sell
937,500
-100,000
-10% -$175K 0.01% 419
2024
Q4
$1.64M Hold
1,037,500
0.01% 470
2024
Q3
$1.63M Buy
1,037,500
+100,000
+11% +$157K 0.01% 433
2024
Q2
$1.67M Hold
937,500
0.01% 410
2024
Q1
$2.68M Buy
+937,500
New +$2.68M 0.02% 350